Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of diabetes mellitus on early and long-term results of percutaneous drug-eluting stent implantation for unprotected left main coronary disease.
Sheiban I, Garrone P, Sillano D, Biondi-Zoccai G, Sciuto F, Omedè P, Lombardi P, Meliga E, Anselmino M, Trevi GP, Moretti C. Sheiban I, et al. Among authors: garrone p. J Cardiovasc Med (Hagerstown). 2008 Dec;9(12):1246-53. doi: 10.2459/JCM.0b013e32830d8303. J Cardiovasc Med (Hagerstown). 2008. PMID: 19001932
Impact of multivessel stenting on top of percutaneous revascularization for unprotected left main disease in the drug-eluting stent era: insights from the Turin registry.
Sheiban I, Sillano D, Biondi-Zoccai G, Moretti C, Garrone P, Lombardi P, Sciuto F, Omedè P, Iacovino C, Spina CL, Trevi GP. Sheiban I, et al. Among authors: garrone p. J Cardiovasc Med (Hagerstown). 2009 Jun;10(6):461-8. doi: 10.2459/JCM.0b013e3283293483. J Cardiovasc Med (Hagerstown). 2009. PMID: 19395977
Temporal trends in baseline characteristics and peri-procedural complications of percutaneous drug-eluting stent implantation for unprotected left main disease: a single high-volume center experience.
Sheiban C, Moretti C, La Spina C, Sillano D, Garrone P, Lombardi P, Sciuto F, Omedè P, Biondi-Zoccai G, Trevi GP. Sheiban C, et al. Among authors: garrone p. Minerva Cardioangiol. 2008 Aug;56(4):381-6. Minerva Cardioangiol. 2008. PMID: 18614981 Clinical Trial.
Contrast-induced kidney injury: how does it affect long-term cardiac mortality?
Andreis A, Budano C, Levis M, Garrone P, Usmiani T, D'Ascenzo F, De Filippo O, D'Amico M, Bergamasco L, Biancone L, Marra S, Colombo A, Gaita F. Andreis A, et al. Among authors: garrone p. J Cardiovasc Med (Hagerstown). 2017 Nov;18(11):908-915. doi: 10.2459/JCM.0000000000000543. J Cardiovasc Med (Hagerstown). 2017. PMID: 28678146 Free article.
AKIGUARD (Acute Kidney Injury GUARding Device) trial: in-hospital and one-year outcomes.
Usmiani T, Andreis A, Budano C, Sbarra P, Andriani M, Garrone P, Fanelli AL, Calcagnile C, Bergamasco L, Biancone L, Marra S. Usmiani T, et al. Among authors: garrone p. J Cardiovasc Med (Hagerstown). 2016 Jul;17(7):530-7. doi: 10.2459/JCM.0000000000000348. J Cardiovasc Med (Hagerstown). 2016. PMID: 26702595 Clinical Trial.
56 results